In 1994, Cochlear Pty. Ltd. (Now Cochlear Limited) released a new speech processor, the Spectra 22, for use with the Nucleus 22-channel cochlear implant. The Spectra 22 speech processor incorporates a new speech processing strategy called SPEAK, which is based upon research conducted by the University of Melbourne. This paper reports post-operative scores on open-set word and sentence materials for adult patients in the Melbourne Cochlear Implant Clinic who have been started up with the Spectra 22 speech processor.